tiprankstipranks
Celon Pharma SA (PL:CLN)
:CLN
Poland Market
CLN
Celon Pharma SA
RESEARCH TOOLSreports
Want to see PL:CLN full AI Analyst Report?

Celon Pharma SA (CLN) Income Statement

0 Followers

Celon Pharma SA Income Statement

Last quarter (Q4 2025), Celon Pharma SA's total revenue was zł53.99M, an increase of 10.00% from the same quarter last year. In Q4, Celon Pharma SA's net income was zł-24.90M. See Celon Pharma SA’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Mar 24Mar 23Mar 22
Total Revenue
zł 209.80Mzł 176.62Mzł 213.92Mzł 161.91Mzł 196.09M
Gross Profit
zł -39.48Mzł 113.45Mzł 147.10Mzł 95.45Mzł 134.37M
Operating Expenses
zł 17.28Mzł 150.26Mzł 174.34Mzł 14.12Mzł 144.82M
Depreciation and Amortization
zł 46.28Mzł 51.86Mzł 50.02Mzł 44.09Mzł 41.34M
EBITDA
zł -10.48Mzł 14.96Mzł 32.71Mzł 9.32Mzł 27.81M
Operating Income
zł -56.76Mzł -36.81Mzł -27.24Mzł -69.76Mzł -10.45M
Other Income/Expenses
zł -2.21Mzł -2.56Mzł 7.27Mzł 890.00Kzł -4.63M
Pretax Income
zł -58.97Mzł -39.37Mzł -19.97Mzł -36.45Mzł -15.09M
Net Income
zł -79.36Mzł -34.45Mzł -28.12Mzł -39.28Mzł -11.61M
Per Share Metrics
Basic EPS
zł -1.47zł -0.66zł -0.55zł -0.77zł -0.25
Diluted EPS
zł -1.47zł -0.66zł -0.55zł -0.77zł -0.25
Weighted Average Shares Outstanding
 53.86M 52.51M 51.06M 51.02M 46.68M
Weighted Average Shares Outstanding (Diluted)
 53.86M 52.52M 51.06M 51.02M 46.68M
Currency in PLN

Celon Pharma SA Earnings and Revenue History